Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

16 Sep 2021 07:00

RNS Number : 9195L
Income & Growth VCT (The) PLC
16 September 2021
 

 

The Income & Growth VCT plc

("the Company")

LEI: 213800FPC15FNM74YD92

 

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2021

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2021. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 June 2021

(unaudited)

At 31 March 2021

(unaudited)

Net assets attributable toshareholders

£120.31 million

£111.95 million

Shares in issue

117,734,097

118,200,511

Net asset value (NAV) per share

102.19 pence

94.71 pence

Cumulative dividends paid

131.50 pence

131.50 pence

Cumulative Total return (net asset value basis) per share since inception

233.69 pence

226.21 pence

The NAV per share has increased by 7.48 pence in the quarter (an increase of 7.9% upon the opening NAV per share). This positive performance is principally due to a continued rise in unrealised portfolio valuations.

 

 

Proposed change in management arrangements

As announced by the Company via RNS on 10 September 2021, Mobeus Equity Partners LLP (Mobeus), the investment adviser to the Company has announced the sale of its VCT fund and investment management business to a subsidiary of Gresham House plc (Gresham House). As part of the sale, the Board has agreed to the novation of the investment advisory arrangements from Mobeus to Gresham House subject to completion of the sale. Gresham House is a fast growing, specialist fund group, with a long-term commitment to the VCT industry and is the existing investment manager of the Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc (the Baronsmead VCTs). The entire core management, investment and operational teams involved with the Mobeus VCTs will all transfer to Gresham House in connection with this transaction to form a significantly enlarged team that will manage both the Mobeus VCTs and the Baronsmead VCTs. The Board can confirm that no material changes are being made to the terms of the investment advisory arrangements. Shareholders can also be assured that the Board's track record of governance and independence will be maintained.

 

 

INTERIM DIVIDEND

The Board declared an interim dividend of 5.00 pence per share for the year ending 30 September 2021. This dividend was paid to Shareholders on 23 July 2021 who were on the Register on 25 June 2021 and brings cumulative dividends paid per share to 136.50 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

 

SHARE BUY-BACKS

 

On 25 June 2021, the Company purchased 466,414 of its own ordinary shares at a price of 85.22 pence per share for cancellation.

 

 

DIVIDEND INVESTMENT SCHEME

 

After the period end, on 23 July 2021, the Company allotted 1,178,669 shares to participants of the Dividend Investment Scheme at a price of 89.71 pence per share, being the latest published NAV at 31 March 2021 of 94.71 pence per share adjusted for the 5.00 pence per share interim dividend. Following this allotment, the Company has 118,912,766 ordinary shares of 1 penny each in issue.

 

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New investments during the period

On 22 June 2021, a new investment of £0.91 million was made into Legatics, a SaaS LegalTech software business.

 

On 25 June 2021, a new investment of £0.84 million was made into Pets' Kitchen (trading as Vet's Klinic), a veterinary clinics business and pet food provider.

 

Follow-on investments during the period

On 16 April 2021 and 18 May 2021, follow-on investments totalling £0.25 million were made into Caledonian Leisure, a provider of UK leisure and experience breaks.

 

On 26 May 2021, a follow-on investment of £0.39 million was made into Bella & Duke, a premium frozen raw dog food provider.

 

On 27 June 2021, a follow-on investment of £0.08 million was made into Spanish Restaurant Group Limited (trading as Tapas Revolution), a Spanish restaurant chain.

Loan repayments during the period

On 1 April 2021, a loan repayment of £0.32 million was received by the Company from Vian Marketing Limited (trading as Red Paddle).

 

On 28 May 2021, a loan repayment of £0.46 million was received by the Company from MPB Group Limited.

 

 

Other proceeds received during the period.

 

On 12 April 2021, the Company received further proceeds of £0.04 million in respect of Vectair Holdings Limited, an investment realised in a previous year.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

Follow-on investments after the period end

On 5 August 2021, a follow-on investment of £0.95 million was made into MyTutor, a digital tutoring marketplace.

 

Partial realisation after the period end

On 6 August 2021, the Company sold part of its original equity holding in MyTutor to a large strategic investor generating proceeds of £0.95 million and a £0.70 million realised gain for the Company over the original cost of the equity shares sold. In isolation, the impact of this partial sale is a 0.10 pence uplift in NAV per share compared to the 30 June 2021 NAV per share of 102.19 pence, referred to above.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

 

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVUNRAWUKAAR
Date   Source Headline
15th May 201812:13 pmRNSHalf-year Report
27th Mar 20184:53 pmRNSTransaction in Own Shares
13th Mar 20184:28 pmRNSIssue of Equity
15th Feb 20185:14 pmRNSDirector/PDMR Shareholding
15th Feb 20185:14 pmRNSIssue of Equity
13th Feb 20189:19 amRNSTransaction in Own Shares
7th Feb 20181:36 pmRNSInterim Management Statement
7th Feb 20181:26 pmRNSAGM Statement
25th Jan 20189:23 amRNSIssue of Equity
5th Jan 201812:38 pmRNSRealisation of investment in Gro-Group
5th Jan 201811:25 amRNSTotal Voting Rights
20th Dec 20175:53 pmRNSTransaction in Own Shares
20th Dec 20171:58 pmRNSPublication of Suppl.Prospcts
14th Dec 20174:53 pmRNSNational Storage Mechanism
12th Dec 201712:41 pmRNSAnnual Financial Report
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:31 amRNSIssue of Equity
21st Nov 201710:05 amRNSIssue of Equity
10th Nov 201710:37 amRNSIssue of Equity
1st Nov 201712:45 pmRNSIncrease in Offer size. Expiry of early incentive.
23rd Oct 201711:34 amRNSOver-allotment facility
20th Oct 20172:25 pmRNSIssue of Equity
2nd Oct 20174:53 pmRNSTransaction in Own Shares
29th Sep 20179:19 amRNSIssue of Equity
21st Sep 20177:00 amRNSInterim Management Statement
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
1st Sep 20178:53 amRNSTotal Voting Rights
31st Aug 20173:47 pmRNSDirector/PDMR Shareholding
31st Aug 20173:43 pmRNSDirector/PDMR Shareholding
31st Aug 20173:40 pmRNSIssue of Equity
4th Aug 20175:11 pmRNSJoint Announcement - Fundraising Update
3rd Aug 20174:46 pmRNSNotice of Results
3rd Aug 20171:58 pmRNSDividend Declaration
3rd Aug 20171:57 pmRNSNet Asset Value(s)
1st Aug 20179:30 amRNSTotal Voting Rights
10th Jul 20174:07 pmRNSTransaction in the Company's own shares
7th Jul 201710:46 amRNSFundraising Update, Circular and General Meetings
5th Jul 201711:34 amRNSRealisation of investment in Entanet Holdings Ltd
3rd Jul 20174:59 pmRNSTotal Voting Rights
20th Jun 20175:55 pmRNSDirector/PDMR Shareholding
20th Jun 20175:46 pmRNSIssue of Equity
24th May 20171:07 pmRNSIntention to launch offers for subscription
24th May 201711:08 amRNSHalf-year Report
16th May 20171:37 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.